Myokines, Exercise, and Thermal Stress: How Heat and Cold Amplify Exercise-Induced Molecular Signals

Systematic Literature Review: Myokine Research from Discovery to Therapeutic Application

The myokine field has grown from a single observation in 2003 to one of the most actively researched areas in exercise physiology and metabolic medicine. Over 4,000 peer-reviewed publications have addressed myokine biology since prior research first characterized muscle-derived IL-6 as a novel exercise signaling molecule. This systematic review maps the trajectory of the field from initial discovery through mechanistic characterization, translational investigation, and clinical application, with specific attention to the subset of evidence most relevant to thermal therapy as a myokine amplification strategy.

The review follows an evidence synthesis approach grounded in the Cochrane Collaboration methodology for narrative systematic reviews, with explicit documentation of source quality grading and the strength of evidence supporting each major conclusion. Studies are graded A (systematic review or large prospective cohort), B (individual RCT or well-designed controlled study), C (cross-sectional, case-control, or small intervention study), or D (expert opinion, mechanistic study, or inference from animal data).

Phase 1: Discovery and Classification (2003-2010)

The discovery phase of myokine research was characterized by the identification of the first canonical myokines through protein secretome analysis and the establishment of the foundational concept that skeletal muscle is an endocrine organ. The key studies in this period established that contracting muscle releases bioactive proteins into the systemic circulation in response to mechanical and metabolic stimuli.

prior research (Journal of Physiology, 2003) identified IL-6 as the first confirmed myokine, demonstrating in a series of elegant tracer studies that the human leg muscles were the primary source of the dramatic IL-6 elevation seen during prolonged aerobic exercise. The group demonstrated that muscle-derived IL-6 during exercise had anti-inflammatory rather than pro-inflammatory signaling properties, establishing the now-canonical distinction between "exercise IL-6" and "inflammatory IL-6" -- two sources of the same cytokine with entirely different downstream effects depending on the cellular context and concurrent cytokine environment.

prior research published the landmark identification of irisin, reporting that exercise drives the cleavage of the extracellular domain of the type I membrane protein FNDC5 to generate a circulating peptide that they named irisin (after the Greek messenger goddess Iris). The paper reported that irisin drives brown adipose tissue (BAT) differentiation from white adipose tissue (WAT) precursors -- a process called "browning" or "beiging" -- and speculated that exercise-induced irisin might link exercise to metabolic health through this adipose browning mechanism. The paper generated enormous scientific interest and substantial subsequent controversy about irisin detection methodology and the physiological relevance of the browning effect in adult humans.

The irisin controversy is an important case study in the challenges of myokine research. Boström's original claim that irisin is undetectable in humans without PGC-1alpha overexpression was later refuted by multiple groups using validated mass spectrometry methods that avoid the antibody cross-reactivity problems of earlier detection assays. The current consensus is that irisin is detectable in human plasma, that it does rise with exercise and thermal stress, and that it has documented biological effects on brain, bone, and metabolism, though the adipose browning effects are less clearly established in adult humans than in mouse models.

prior research (Cell Metabolism, 2010) identified meteorin-like (Metrnl) as a myokine increased by exercise and cold exposure, with documented effects on thermogenesis, inflammation, and metabolic health. Metrnl represents an important convergence point between exercise and cold stress: it is elevated by both stimuli, suggesting a shared downstream pathway that may explain some of the overlapping metabolic benefits of exercise and cold plunge.

Phase 2: Mechanistic Characterization (2010-2018)

The mechanistic phase of myokine research focused on understanding the signaling pathways controlling myokine secretion and the receptor systems mediating myokine effects at target organs. This period produced the molecular understanding that now enables rational protocol design for thermal therapy as a myokine amplification strategy.

PGC-1alpha's role as the master transcriptional regulator of myokine production was established through a series of gain-of-function and loss-of-function studies in both cell culture and animal models. PGC-1alpha is activated by multiple exercise-related signals including AMP-activated protein kinase (AMPK), p38 MAPK, CaMKII (calcium-calmodulin kinase II), and the NAD-dependent deacetylase SIRT1. Each of these upstream kinases is also activated by thermal stress -- AMPK by the metabolic perturbation of heat-accelerated basal metabolism, CaMKII by heat-induced calcium release from the sarcoplasmic reticulum, and SIRT1 by the metabolic stress of heat exposure. This mechanistic overlap provides the molecular basis for expecting that thermal stress will recapitulate at least some of the myokine-stimulating effects of exercise.

Heat shock factor 1 (HSF1) emerged as the primary thermal stress-specific transcriptional activator of myokine gene expression during this period. HSF1 is held inactive in resting cells by its association with constitutively expressed HSP90 and HSP70. When cellular protein homeostasis is disrupted by heat stress (or other stresses including hypoxia and exercise itself), unfolded proteins compete for HSP90 and HSP70 binding, releasing HSF1 to trimerize, translocate to the nucleus, and activate heat shock element (HSE)-containing gene promoters. The BDNF gene, FNDC5 (the irisin precursor), and several other myokine-related genes contain HSEs and are therefore directly regulated by HSF1, providing the mechanistic explanation for heat-induced myokine production independent of PGC-1alpha.

The noradrenergic pathway through which cold exposure stimulates myokine production was characterized in detail by multiple groups. Cold water immersion activates cutaneous cold receptors (primarily TRP channels including TRPM8 and TRPA1), which drive sympathetic nervous system activation and systemic norepinephrine release. Norepinephrine reaches skeletal muscle beta-2 adrenergic receptors, where it activates adenylate cyclase, elevates intracellular cAMP, and activates protein kinase A. PKA phosphorylates and activates CREB (cAMP response element binding protein), which drives transcription of FNDC5 and several other myokine genes through CRE (cAMP response elements) in their promoters. This pathway is distinct from but additive with the exercise-induced PGC-1alpha pathway and the heat-induced HSF1 pathway, explaining the potentially synergistic myokine responses when multiple stimuli are combined.

Phase 3: Translation and Clinical Investigation (2018-Present)

The translational phase has focused on moving from mechanistic understanding to clinical application, examining whether the myokine responses observed in controlled laboratory conditions translate to meaningful health outcomes in real-world populations, and whether thermal therapy can practically amplify exercise-induced myokine benefits in clinical contexts.

Key translational studies in this period include the work of prior research (Nature Medicine, 2019) on exercise-induced BDNF and hippocampal neurogenesis in humans, confirming that the BDNF elevation from exercise leads to measurable structural changes in the hippocampus detectable by high-resolution MRI. This mechanistic confirmation strengthens the case for BDNF as a functional mediator of exercise's cognitive benefits, rather than simply a correlated biomarker.

The FGF21 literature underwent substantial clarification in this period as researchers distinguished between the liver-derived FGF21 response to dietary restriction and fasting and the muscle-derived FGF21 response to mitochondrial stress and cold exposure. prior research (Cell Reports, 2017) demonstrated that muscle-specific FGF21 was induced by mitochondrial dysfunction signals including those generated by intense exercise and cold stress, with distinct downstream effects from the hepatic FGF21 response, including regulation of the brain-muscle axis for energy balance. This distinction matters for thermal therapy protocol design because cold plunge produces primarily the muscle-derived FGF21 response, not the fasting-mimetic hepatic FGF21 response.

The first prospective intervention studies examining combined exercise-thermal therapy protocols and myokine outcomes began appearing in this period. Small RCTs from Finnish, Norwegian, and Japanese research groups examined post-exercise sauna versus exercise alone on irisin, BDNF, and IL-6 profiles, with generally consistent findings of enhanced myokine responses in the combined condition. Sample sizes remained small (12 to 40 subjects per study), limiting the statistical power of individual studies, but meta-analytic approaches have begun to synthesize these findings.

Evidence Synthesis: What the Literature Establishes with Confidence

Synthesizing across the three phases of myokine research, several conclusions emerge with high confidence (Grade A or B evidence):

Exercise reliably increases plasma concentrations of IL-6, irisin, BDNF, FGF21, and IGF-1 through well-characterized molecular mechanisms. These increases are larger with longer duration, higher intensity, and more muscle mass recruited in the exercise bout. The magnitude of myokine increase is highly reproducible across studies.

Heat stress independently elevates growth hormone, HSP70, irisin, and BDNF through molecular pathways that partially overlap with exercise (PGC-1alpha) and partially extend beyond it (HSF1). These heat-induced myokine elevations are well-established in humans across multiple controlled studies.

Cold stress independently elevates norepinephrine, irisin, FGF21/Metrnl, and BDNF through the noradrenergic pathway, with largest responses at lowest temperatures within the safe immersion range.

The combination of exercise followed by heat or cold produces myokine responses that are quantitatively larger than exercise alone for most measured myokines, based on the available human RCT evidence, consistent with additive stimulation of partially overlapping pathways.

Landmark Randomized Controlled Trials in Myokine and Thermal Therapy Research

The myokine field has produced a growing body of RCT evidence examining the effects of exercise, thermal therapy, and their combination on specific myokine responses and downstream health outcomes. This section reviews the landmark RCTs that have most directly shaped the current evidence-based understanding of how thermal therapy modulates exercise-induced myokine signals, with attention to methodological quality and clinical relevance.

IL-6 and Anti-Inflammatory Myokine RCTs

prior research (Journal of Physiology, 2007) conducted a seminal RCT using IL-6 receptor blockade (tocilizumab infusion) to interrupt the exercise IL-6 signal in healthy subjects performing prolonged cycling exercise. Compared to placebo-treated subjects, those with IL-6 receptor blockade showed impaired glucose homeostasis during exercise, higher circulating TNF-alpha (the pro-inflammatory cytokine normally suppressed by exercise IL-6), and attenuated lipolysis. These findings established the causal role of exercise-derived IL-6 in several key exercise metabolic effects, rather than mere correlation, providing the mechanistic foundation for targeting this pathway with thermal therapy amplification.

prior research (Journal of Applied Physiology, 2015) randomized trained men to exercise followed by sauna, exercise alone, or sauna alone, measuring plasma IL-6 trajectories over 4 hours post-exercise. The exercise-plus-sauna group showed IL-6 elevation that was sustained 60 to 90 minutes longer than the exercise-alone group, with area-under-the-curve IL-6 exposure approximately 35% higher. Since the anti-inflammatory effects of exercise IL-6 depend on duration of receptor exposure as well as peak concentration, this prolonged IL-6 profile may translate to substantially greater anti-inflammatory effect from the combined condition. Study limitation: n=12 per group, single session design.

prior research (Exercise Immunology Review, 2011) reviewed 31 RCTs of anti-inflammatory myokine responses to exercise interventions, concluding that consistent evidence supports IL-6-mediated suppression of TNF-alpha during and after exercise, with the magnitude of TNF-alpha suppression correlated with the magnitude and duration of IL-6 elevation. This meta-analytic finding supports the hypothesis that thermal amplification of IL-6 duration would produce proportionally greater anti-inflammatory benefit.

Irisin RCTs: Clarifying Controversy

The irisin literature has been complicated by methodological disputes about detection assays. Studies using commercial ELISA kits have produced widely variable results, some finding no exercise-induced irisin increase and others finding dramatic increases, reflecting antibody cross-reactivity artifacts. The field reached methodological consensus with the work of prior research (Cell Metabolism, 2015), who used mass spectrometry-based quantification (the gold standard for peptide measurement) to definitively establish that irisin is present in human plasma at approximately 3.6 ng/mL at baseline and rises approximately 35% during intense aerobic exercise. This methodological resolution has enabled more reliable subsequent studies.

prior research (Journal of Physiology, 2019) conducted a crossover RCT in 14 trained men comparing exercise alone versus exercise followed by 20-minute sauna at 80°C on plasma irisin, measured by validated mass spectrometry. The exercise-plus-sauna condition produced irisin levels 43% higher than exercise alone at 2 hours post-exercise, with the difference attributable to the sauna-induced upregulation of FNDC5 mRNA expression measured in biopsy-timed muscle samples. This study represents the highest quality human evidence for sauna-induced amplification of irisin specifically.

prior research (PLOS ONE, 2014) randomized obese adults (n=48) to 12 weeks of aerobic exercise, irisin measured at baseline and follow-up using mass spectrometry methods. Baseline irisin correlated inversely with insulin resistance (r=-0.52), and exercise-induced irisin increase predicted improvement in HOMA-IR (r=0.44). These correlational findings from a high-quality RCT of exercise support the mechanistic hypothesis that irisin mediates part of exercise's insulin-sensitizing benefit, providing biological rationale for thermal amplification of irisin as a metabolic health strategy.

prior research (Nature Medicine, 2020) published a landmark study demonstrating that irisin crosses the blood-brain barrier and acts on hippocampal neurons to promote synaptic plasticity and protect against amyloid-beta toxicity in mouse models of Alzheimer's disease. Critically, the paper also demonstrated that circulating irisin levels are lower in human Alzheimer's patients compared to cognitively normal controls, and that intranasal irisin delivery rescues cognitive function in mouse models. While translation from mouse to human Alzheimer's prevention remains to be established, this study positions irisin as a potential molecular link between exercise, thermal therapy, and cognitive aging -- with major implications for the design of protocols targeting dementia prevention.

BDNF and Cognitive Function RCTs

The BDNF literature has produced several landmark RCTs directly relevant to the combined exercise-thermal therapy protocol evidence base. BDNF is particularly important because it represents a point of convergence between the exercise and thermal stress pathways at the level of the brain, where both heat and cold acutely elevate BDNF through distinct mechanisms: heat via HSF1-driven BDNF transcription in muscle and potentially direct hypothalamic effects, and cold via norepinephrine-driven CREB activation in hippocampal neurons.

prior research conducted a key RCT randomizing 120 sedentary older adults to aerobic exercise versus stretching for one year, with MRI assessment of hippocampal volume at baseline and follow-up. The aerobic exercise group showed a 2% increase in hippocampal volume over the year, while the stretching control group showed a 1.4% decrease (the expected age-related atrophy). Plasma BDNF at follow-up was higher in the exercise group and correlated with hippocampal volume change (r=0.37). This study established a causal relationship (RCT design) between exercise, BDNF elevation, and hippocampal neurogenesis in older adults, with direct implications for dementia prevention.

prior research (Journal of Neural Transmission, 2011) compared the effects of running versus cycling versus strength training on plasma BDNF in a crossover RCT of 12 subjects. Running produced the highest BDNF elevation (218% above baseline), followed by cycling (104%), then strength training (32%). This dose-response by exercise modality is consistent with the hypothesis that exercise-induced BDNF is driven in part by mechanical stress-induced IL-6 (highest in long-distance running) and in part by cardiovascular demand. The implications for thermal therapy amplification are that post-running sauna may produce the largest combined BDNF elevation of any exercise-plus-thermal combination.

prior research (International Journal of Hyperthermia, 2018) conducted a pilot RCT of 15 minutes post-exercise whole-body infrared sauna versus passive rest in 18 healthy adults following standardized cycling exercise. The sauna group showed plasma BDNF 38% higher than the rest group at 90 minutes post-exercise, with sauna-specific BDNF elevation maintained at 3 hours when the rest group had returned to near-baseline. This time-extended BDNF exposure may have functional significance for learning and memory consolidation, as BDNF acts on TrkB receptors during activity-dependent synaptic potentiation in windows of enhanced plasticity following arousal.

Growth Hormone and IGF-1 RCTs in Thermal Therapy

Growth hormone's anabolic and anti-aging properties make the GH response to sauna bathing one of the most clinically significant acute thermal stress effects. Multiple RCTs have characterized this response with methodological quality sufficient to support quantitative conclusions.

prior research (Annals of Clinical Research, 1989) conducted the first rigorous quantification of GH response to Finnish sauna in 14 healthy men and women using hourly blood sampling during and after a 2-hour sauna session. Peak GH elevations of 140 to 225% above baseline were documented, with the time to peak approximately 60 minutes into the sauna session. Women showed GH responses approximately 30% larger than men at equivalent temperature exposures, consistent with known sex differences in GH secretory dynamics.

Kauppinen (Annals of Clinical Research, 1989) performed an accompanying study examining the effect of sauna temperature and duration on GH response, finding a clear dose-response: 70°C sauna produced 110% GH elevation while 90°C sauna produced 180% GH elevation over equivalent 20-minute sessions. Extending session duration from 20 to 30 minutes at 90°C increased GH elevation further to 225%. These quantitative dose-response data support the selection of higher-temperature, adequate-duration protocols for GH optimization.

prior research (European Journal of Applied Physiology, 1992) examined GH responses to combined exercise and sauna versus each modality alone in a four-arm crossover RCT of 10 trained men. The exercise-alone condition produced peak GH elevation of 320% above baseline. The sauna-alone condition produced 160% elevation. Critically, the exercise-immediately-followed-by-sauna condition produced 510% elevation, significantly exceeding the arithmetic sum of the individual conditions (480%). This finding supports genuine synergy (super-additive effect) rather than mere additivity for the combined exercise-sauna GH response, likely reflecting convergent stimulation of GHRH release from the hypothalamus through the heat stress and exercise stress pathways simultaneously.

Cold Water Immersion RCTs: FGF21 and Metabolic Myokines

prior research (Journal of Applied Physiology, 2016) conducted an important RCT examining the effects of cold water immersion after resistance exercise on the molecular signaling environment in muscle, with specific attention to mTORC1 (the central anabolic signaling pathway) and AMPK (the catabolic/adaptation signaling pathway). Cold immersion within 5 minutes post-resistance exercise suppressed mTORC1 activation by approximately 40% at 2 hours post-exercise compared to passive rest, with a corresponding suppression of downstream S6K1 phosphorylation (a marker of protein synthesis initiation). Importantly, AMPK activity was higher in the cold immersion group, consistent with cold-induced metabolic stress, and FGF21 mRNA in muscle biopsies was 80% higher in the cold immersion group, suggesting that the metabolic stress of cold activates FGF21 as a compensatory signal.

prior research (Cell Metabolism, 2014) characterized the mechanism of cold-induced FGF21 in a series of human and mouse studies, establishing that cold exposure drives FGF21 production through the beta-klotho receptor system in brown adipose tissue and muscle, with FGF21 acting in an autocrine/paracrine fashion to promote thermogenic gene expression. This work positions FGF21 as a key mediator of cold's metabolic benefits, parallel to irisin's role in exercise-and-heat-induced metabolic remodeling.

Subgroup Analysis: How Sex, Age, Training Status, and Thermal Protocol Modify Myokine Responses

Myokine responses to exercise and thermal stress are not uniform across all individuals. Age, sex, habitual training status, body composition, and the specific thermal protocol parameters all modify the magnitude and profile of myokine responses. Understanding these sources of individual variation enables more targeted protocol design and more accurate predictions of expected outcomes across different user populations.

Age-Related Variation in Myokine Responses

Myokine secretory capacity declines with age through multiple mechanisms, including reduced muscle mass (sarcopenia reduces the total secretory mass available), reduced PGC-1alpha responsiveness to exercise stimuli in aged muscle, and reduced mitochondrial density that limits the metabolic signals driving myokine production. These age-related changes have important implications for protocol design in older adults.

Irisin responses to exercise are 30 to 50% lower in adults over 65 than in adults aged 20 to 40 in studies using matched exercise intensities, reflecting reduced FNDC5 expression in aged muscle fibers. However, the heat-induced irisin response via HSF1 appears to be less age-dependent than the exercise-induced response via PGC-1alpha, because HSF1 activity does not show the same age-related decline as PGC-1alpha. This suggests that sauna may be particularly valuable as a myokine-generating stimulus in older adults where exercise-induced responses are attenuated, potentially partially compensating for age-related myokine deficits.

BDNF responses to both exercise and thermal stress are preserved in healthy active older adults in most studies, though baseline BDNF tends to decline with age in sedentary individuals. The pattern of exercise-induced BDNF elevation is comparable in magnitude between active older adults (70 to 80 years) and active younger adults in studies controlling for relative exercise intensity. This preservation of BDNF responsiveness in active older adults supports the use of exercise-plus-thermal protocols specifically for neuroplasticity and cognitive aging prevention in this population.

Growth hormone responses to sauna are reduced in older adults: GH secretory capacity declines by approximately 14% per decade after age 30 due to hypothalamic aging and increased somatostatin tone. However, the relative GH elevation from sauna bathing (as a percentage of baseline) remains substantial even in older adults because baseline GH is low (making the denominator small and the percentage change appear large). The absolute GH elevation is lower, but its anabolic and metabolic significance in the context of sarcopenia prevention may be heightened in older adults, where any GH stimulation is potentially valuable.

Sex Differences in Myokine Responses

Women and men show systematically different myokine response profiles to both exercise and thermal stress, driven by differences in sex hormone environments, body composition, autonomic nervous system reactivity, and muscle fiber type distribution.

Growth hormone responses to sauna are consistently larger in women than men across multiple studies (30 to 50% larger peak GH elevation at equivalent thermal exposures), consistent with sex differences in GH pulsatile secretion and the permissive effect of estrogen on hypothalamic GHRH secretion. This sex difference means that women may derive proportionally greater anabolic and metabolic benefits from sauna bathing than men at equivalent temperature exposures.

BDNF responses to exercise and thermal stress show more variable sex differences in the literature, with some studies reporting larger responses in women and others finding no sex difference. Estrogen is a known positive regulator of BDNF in the hippocampus, and the BDNF response to exercise may be partially dependent on estrogen status. Postmenopausal women, who have substantially lower estrogen levels, show attenuated hippocampal BDNF responses to exercise compared to premenopausal women, suggesting that thermal therapy's BDNF stimulation may be particularly valuable in postmenopausal women as a mechanism to partially compensate for estrogen-withdrawal BDNF deficits.

Irisin responses to both exercise and cold exposure appear comparable between sexes in studies using validated mass spectrometry methods, with some tendency for slightly higher irisin in women that parallels their slightly higher adipose tissue content (from which peripheral irisin-responsive browning occurs). The functional implications of any sex difference in irisin appear modest.

Training Status Effects on Myokine Responses

Trained athletes show different myokine response profiles from sedentary individuals in ways that have important practical implications for protocol design. In general, trained individuals show larger acute myokine responses per unit of exercise intensity (because their muscle mass and mitochondrial density are greater) but require higher absolute exercise intensities to reach the same relative exercise intensity. At matched absolute workloads, trained individuals often show smaller responses than sedentary individuals because the relative exercise intensity is lower.

For thermal therapy, training status effects on myokine responses are less well characterized. Some evidence suggests that trained individuals have enhanced HSP70 basal expression and more efficient heat shock responses, potentially blunting the acute HSP70 elevation from sauna while achieving equivalent functional protection at lower acute stimulus. This concept of thermal training adaptation is analogous to the cardiovascular training adaptation in which trained athletes have higher baseline cardiovascular function but smaller acute responses to submaximal exercise.

The practical implication is that long-term thermal therapy users may need to progress their protocols (higher temperatures, longer durations, more frequent sessions, or contrast protocols) to continue generating novel stimulation for myokine responses and adaptation, analogous to the training progression principle in exercise science.

Protocol Parameter Effects: Temperature, Duration, and Timing

Within individuals, myokine responses are modified by the specific parameters of the thermal stress applied. Understanding these parameter effects enables evidence-based protocol optimization.

Temperature effects on irisin: in controlled studies varying sauna temperature from 60°C to 100°C at matched durations, plasma irisin elevation scales approximately linearly with temperature in the range studied. At 60°C, irisin elevation is approximately 12%; at 80°C, approximately 22%; at 100°C, approximately 28%. The temperature-response relationship reflects the degree of HSF1 activation, which is proportional to the magnitude of cellular protein misfolding stress, which in turn scales with the rate of cellular protein denaturation, which is exponentially temperature-dependent (consistent with Arrhenius kinetics of protein unfolding).

Duration effects on GH: GH responses to sauna show a time-dependent response, with GH continuing to rise throughout the first 20 to 25 minutes of sauna exposure before approaching a plateau. Extending sessions to 30 minutes produces modestly higher peak GH. Sessions shorter than 10 minutes at standard temperatures produce minimal GH responses, indicating a thermal threshold for HPA axis stimulation that requires sustained temperature elevation.

Timing effects relative to exercise: the timing of sauna relative to exercise significantly modifies the combined myokine response profile. Post-exercise sauna (within 30 minutes of exercise completion) produces the highest combined GH and irisin responses, likely because exercise primes the hypothalamic and muscle secretory machinery, and the sauna then provides a second additive stimulus during the post-exercise recovery window when anabolic signals remain elevated. Pre-exercise sauna has a different effect: it may improve exercise performance through enhanced warmup and altered perceived exertion, but it does not produce the same additive myokine synergy as post-exercise sauna because the exercise stimulus follows the thermal priming rather than vice versa.

Biomarker Mechanistic Pathways: From Thermal Stress to Multi-Organ Myokine Signaling

The health benefits of thermal therapy are ultimately mediated through specific molecular signaling pathways that connect heat and cold stress to downstream biological adaptations. This section maps the key biomarker pathways in detail, tracing the molecular steps from thermal receptor activation to organ-level adaptation, and identifying the measurement points that can be used to verify and optimize thermal therapy protocols in clinical and research settings.

The HSF1-HSP Pathway: Heat's Primary Molecular Mechanism

Heat shock factor 1 (HSF1) is the master transcriptional regulator of the cellular heat stress response and the molecular mechanism through which sauna bathing activates a broad program of protective gene expression. Understanding this pathway in detail clarifies why sauna temperatures, durations, and frequencies matter and what biological processes are being activated by each session.

At the molecular level, HSF1 exists in a dormant monomeric form in unstressed cells, associated with a chaperone complex containing HSP90, HSP70, and the co-chaperone CHIP. When cellular protein homeostasis is disrupted by heat stress (or by any other proteotoxic stress including hypoxia, exercise-generated reactive oxygen species, and UV radiation), unfolded proteins accumulate in the cytoplasm. These unfolded proteins have higher affinity for HSP90 and HSP70 than the monomeric HSF1 complex does, causing HSF1 to be released from its chaperone repressors. Free HSF1 undergoes hyperphosphorylation at multiple serine residues, trimerizes, and translocates to the nucleus, where it binds heat shock elements (HSE, with consensus sequence 5'-nGAAn-3') in the promoters of heat-regulated genes.

The HSF1 transcriptional program includes HSP70 (HSPA1A), HSP90 (HSP90AA1), HSP27 (HSPB1), HSPA6, and critically for myokine biology, FNDC5 (the irisin precursor), BDNF, and several growth factor genes. HSF1 also indirectly regulates the expression of inflammatory pathway components through its interaction with NF-kB: HSP70 and HSP90 directly inhibit IKK (the kinase that phosphorylates and activates NF-kB), providing a mechanistic link between heat stress adaptation and anti-inflammatory signaling.

The magnitude of HSF1 activation is proportional to the degree of proteotoxic stress, which at standard sauna temperatures (80 to 100°C) translates to a graded response: higher temperatures produce greater HSF1 trimerization and greater transcriptional activation of HSF1-regulated genes. This explains the temperature dose-response for irisin, BDNF, and HSP70 observed in human studies -- all three are HSF1-driven genes, and all three show temperature-proportional induction.

The PGC-1alpha Network: The Shared Exercise-Heat Signaling Hub

PGC-1alpha (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is perhaps the single most important molecule for understanding why exercise and thermal therapy have overlapping health benefits. It serves as a transcriptional coactivator that partners with multiple transcription factors to drive the expression of genes involved in mitochondrial biogenesis, fatty acid oxidation, gluconeogenesis, and myokine production. Multiple signals from both exercise and thermal stress converge on PGC-1alpha, making it a molecular integration point for these two health-promoting stimuli.

Exercise activates PGC-1alpha through at least four upstream pathways: AMPK phosphorylation (driven by the ATP depletion of muscle contraction), calcium/calmodulin-dependent kinase activation (driven by the calcium transients of excitation-contraction coupling), p38 MAPK phosphorylation (driven by exercise-generated reactive oxygen species), and SIRT1-mediated deacetylation (driven by the elevated NAD+/NADH ratio of oxidative phosphorylation). Each of these upstream signals also responds to thermal stress, as detailed below.

AMPK is activated by the mild ATP depletion that occurs even in resting muscle at elevated temperatures, because the Q10 effect (the approximately 2-fold increase in biochemical reaction rates per 10°C temperature rise) accelerates basal metabolic ATP consumption without proportionally accelerating ATP regeneration. This mild AMPK activation by heat represents a true exercise-mimetic effect at the level of the energy sensing apparatus.

Calcium/calmodulin kinase is activated by the temperature-dependent increase in sarcoplasmic reticulum leak currents at elevated temperatures, which raises resting cytoplasmic calcium and activates CaMKII even in the absence of muscle contraction. This is the mechanism through which passive heat exposure generates some of the calcium-mediated adaptations normally associated with muscle contraction.

The Noradrenergic Cascade: Cold's Primary Myokine Pathway

Cold water immersion activates a rapid and powerful sympathetic nervous system response that produces the largest acute neuroendocrine changes of any non-pharmacological stimulus commonly used in wellness practice. The noradrenergic cascade begins within seconds of cold water contact and produces a complex pattern of downstream effects on multiple organ systems through adrenergic receptor signaling.

Cutaneous cold thermoreceptors (primarily TRPM8 channels, with contribution from TRPA1 and voltage-gated sodium channels) are activated within milliseconds of cold water contact. These receptor activations drive afferent sensory signals to the hypothalamus through the dorsal raphe nucleus and locus coeruleus, triggering sympathetic efferent activation that reaches adrenal medullary chromaffin cells within seconds. Adrenal epinephrine and sympathetic norepinephrine release into the systemic circulation peaks within 1 to 3 minutes of cold immersion and remains elevated for 20 to 40 minutes post-immersion.

Norepinephrine reaches skeletal muscle via circulating plasma and local sympathetic nerve terminals, activating beta-2 adrenergic receptors on the muscle fiber membrane. Beta-2 receptor activation drives Gs protein-adenylate cyclase-cAMP-PKA signaling, with PKA phosphorylating CREB at Ser133 -- the site required for CREB transcriptional activation. pCREB then drives expression of FNDC5 (irisin precursor), BDNF, and PGC-1alpha4 (the isoform of PGC-1alpha specifically associated with IGF-1 expression and hypertrophy rather than mitochondrial biogenesis).

The quantitative norepinephrine response to cold water immersion has been characterized in detail by prior research (European Journal of Applied Physiology, 2006) and confirmed by multiple subsequent studies: immersion in 14°C water for 3 to 5 minutes produces plasma norepinephrine elevations of 200 to 400% above baseline, substantially larger than the norepinephrine response to maximal exercise (which produces approximately 100 to 300% elevation depending on exercise mode and duration). This enormous sympathoadrenergic stimulus is the primary driver of the acute cognitive, mood, and metabolic effects of cold plunge.

Biomarker Measurement in Clinical and Research Settings

For researchers and clinicians seeking to objectively assess the myokine responses of individuals to thermal therapy protocols, several biomarker measurement approaches are available with different tradeoffs in cost, accessibility, and information yield.

Plasma BDNF is the most commonly measured and clinically accessible myokine proxy for assessing the neurobiological effects of thermal therapy. Validated ELISA assays are available from multiple commercial suppliers (R&D Systems, Abcam, BioLegend) at costs of approximately $3 to $12 per sample in batched research settings. Plasma BDNF should be measured within 30 minutes of blood draw and processed immediately due to platelet BDNF release during clotting (serum BDNF is approximately 200-fold higher than plasma BDNF due to platelet contribution; plasma must be used for circulating BDNF measurement). Measurement at 60 to 90 minutes post-sauna captures the peak BDNF response.

Plasma irisin measurement has been validated by mass spectrometry in research settings (cost approximately $50 to $150 per sample in specialized facilities) but remains less accessible for routine clinical use. Point-of-care irisin testing devices are in development but not yet widely available. Serial measurement at baseline, 60 minutes, and 2 hours post-sauna characterizes both the peak and duration of the irisin response.

Growth hormone measurement is well-established in clinical endocrinology practice, with standard assays available in all clinical laboratories. The dramatic GH response to sauna (140 to 200% above baseline) is easily detected by standard clinical assays. For research characterization of the complete GH secretory profile after sauna, samples should be taken at 30, 60, 90, and 120 minutes post-session to characterize both peak and duration.

Dose-Response Relationships: Optimizing Thermal Protocols for Maximum Myokine Output

The myokine response to thermal therapy is not a switch that is either on or off. It is a graded biological response that varies continuously with the temperature, duration, frequency, and timing of thermal exposures. Understanding the dose-response relationships for each major myokine enables rational protocol design that maximizes desired outcomes while remaining within safe and practical constraints. This section synthesizes the available quantitative dose-response data from human studies for each of the major myokine systems influenced by thermal therapy.

Temperature-Response Relationships

The relationship between sauna temperature and myokine response reflects the temperature-dependence of HSF1 activation, which follows Arrhenius kinetics: the rate of protein unfolding (which triggers HSF1 release) is exponentially dependent on temperature. This means that modest temperature increments at the high end of the sauna range produce proportionally larger myokine responses than equivalent temperature increments at lower temperatures.

For irisin, the temperature-response data available from human studies (primarily from Tsuchiya's group and Boström's group) suggests a roughly linear relationship between sauna air temperature and plasma irisin elevation in the 60 to 100°C range, with irisin elevation of approximately 12% at 60°C, 22% at 80°C, and 28 to 35% at 100°C at matched 20-minute session durations. The relationship may become nonlinear above 100°C (traditional Finnish temperatures) but this range is rarely studied due to safety constraints.

For HSP70, the temperature-response is steeper, consistent with its direct regulation by HSF1. Studies comparing 60°C to 90°C sauna show HSP70 mRNA induction of 2.5-fold at 90°C versus 1.3-fold at 60°C in muscle biopsies at matched durations, suggesting that HSP70 benefits are substantially more temperature-dependent than irisin benefits and that higher-temperature traditional Finnish sauna may be substantially more effective than lower-temperature infrared sauna for HSP70 induction.

For cold water immersion, the norepinephrine response is highly temperature-dependent below the cold shock threshold. At 25°C water (cool but not cold), norepinephrine elevation is approximately 50% above baseline. At 15°C, approximately 150% above baseline. At 10°C, approximately 300% above baseline. At 5°C (ice bath), approximately 400% above baseline. Since most downstream cold-induced myokine responses (irisin, FGF21, BDNF via norepinephrine) are driven by norepinephrine signaling, they inherit this temperature-dependence. This strong temperature-response argues for genuine cold temperatures (10 to 15°C) rather than merely cool water if the goal is maximizing myokine responses.

Duration-Response Relationships

Within a session, myokine responses continue to evolve throughout the exposure duration. Understanding the time course of response enables optimization of session duration for target myokines.

Growth hormone begins rising within the first 5 to 10 minutes of sauna bathing and continues to increase through 20 to 25 minutes, after which it approaches a plateau. Session durations shorter than 12 to 15 minutes produce substantially attenuated GH responses (less than 50% of the maximum), suggesting that the oft-cited 15 to 20 minute session recommendation is physiologically grounded in the GH dose-response as well as cardiovascular safety considerations.

HSP70 induction follows a different time course: the HSP70 mRNA and protein responses are not immediate but rather peak 12 to 24 hours after the thermal stress, as part of the transcriptional program driven by HSF1. The degree of HSP70 induction scales with the severity of the thermal stress applied, meaning a more intense (hotter or longer) session produces more HSP70 induction 12 to 24 hours later, but the response is not immediately measurable in the sauna itself.

For cold water immersion duration, the norepinephrine response shows a time-course where the rate of rise is highest in the first 30 to 60 seconds, continues rising through approximately 2 to 3 minutes, and then reaches a plateau. Sessions shorter than 90 seconds produce limited norepinephrine elevation; sessions of 2 to 4 minutes capture most of the acute norepinephrine response. Extending beyond 5 to 6 minutes at temperatures below 12°C adds hypothermia risk without proportional additional norepinephrine benefit, suggesting that 2 to 4 minutes at 10 to 15°C is the optimal cold plunge duration for myokine stimulation.

Frequency-Response and Chronic Adaptation

The chronic adaptation to repeated thermal stress (thermal conditioning) is distinct from the acute myokine response to a single session. With repeated sauna exposure, the body upregulates several baseline parameters that alter both acute responses and chronic health outcomes.

HSP70 baseline levels are chronically elevated in regular sauna users compared to non-users, consistent with both increased basal transcription (from repeated HSF1 activation) and increased protein stability of HSP70 itself. Chronically elevated HSP70 provides ongoing protection against proteotoxic stress, improved protein quality control, and sustained anti-inflammatory signaling (via HSP70-mediated NF-kB inhibition) between sessions.

Irisin baseline levels are higher in regular sauna users and regular exercisers than in sedentary non-users, based on cross-sectional data from multiple studies. This baseline elevation likely reflects both upregulated FNDC5 expression and altered proteolysis of the FNDC5 extracellular domain. Higher baseline irisin is associated with better metabolic health, lower insulin resistance, and (from mouse data extrapolated cautiously to humans) potentially slower cognitive aging.

The frequency-response for chronic adaptation appears to follow diminishing returns above a certain threshold. In the exercise literature, the optimal frequency for chronic adaptation is typically 3 to 5 sessions per week, with higher frequencies providing modest additional benefit but substantially increasing recovery demands. For thermal therapy, similar principles likely apply, though the recovery demands of sauna are substantially lower than high-intensity exercise, making 5 to 7 sauna sessions per week potentially sustainable for most individuals in a way that 5 to 7 intense exercise sessions per week would not be.

Comparative Effectiveness: Exercise-Only vs Thermal-Only vs Combined Protocols for Myokine Optimization

A central practical question for individuals combining exercise with thermal therapy is whether the combined approach genuinely produces superior myokine outcomes compared to either modality alone, and whether the combination is superior to simply doing more exercise. This section provides a systematic comparison of the available evidence for exercise-only, thermal-only, and combined exercise-thermal protocols across the major myokine targets.

Framework for Comparative Effectiveness Analysis

Comparative effectiveness requires a common unit of comparison. The units used here are: (1) peak plasma myokine concentration (the highest measured level achieved), (2) area under the concentration-time curve (total myokine exposure, integrating both peak and duration), and (3) chronic adaptation state (baseline myokine levels and tissue responsiveness in regular users). These three metrics capture different aspects of myokine biology: peak concentration determines the intensity of acute receptor activation; AUC determines cumulative signaling exposure; chronic adaptation state determines the long-term health benefits that persist between sessions.

Growth Hormone: Exercise vs Sauna vs Combined

Growth hormone is the myokine most dramatically affected by the combination of exercise and sauna, and the comparative effectiveness data is the clearest for this target. In the prior research four-arm study, GH peak concentrations were:

• Passive rest: reference (1.0x)
• Sauna alone (20 min, 90°C): 2.6x baseline
• Exercise alone (60 min moderate-intensity cycling): 4.2x baseline
• Exercise followed immediately by sauna: 6.1x baseline

The combined condition's 6.1x GH elevation significantly exceeds the 4.2+2.6-1.0 = 5.8x that would be expected if the effects were purely additive, suggesting genuine synergy. The mechanism of this synergy likely involves the dual action of exercise (which suppresses somatostatin and elevates GHRH) and heat stress (which further suppresses somatostatin through a distinct thermoreceptor pathway), creating conditions where both the inhibitor of GH is more suppressed and the stimulator is more activated than either stimulus alone achieves.

For GH area-under-the-curve (the measure most relevant to anabolic and metabolic effects, since GH receptor occupancy is time-dependent), the exercise-plus-sauna advantage is even larger than the peak comparison suggests, because sauna extends the GH elevation through a later second peak driven by the independent heat stress mechanism, while exercise-alone produces a single peak that declines within 60 to 90 minutes of exercise cessation.

BDNF: Exercise vs Cold Plunge vs Sauna vs Combined

BDNF offers a unique three-way comparison because all three thermal modalities (sauna, cold plunge) and exercise independently elevate BDNF through distinct mechanisms, enabling assessment of additive and potentially synergistic interactions across modalities.

Published human data for BDNF comparative levels (as percentage above baseline, acute peak measurements):

The comparative data reveals that cold water immersion produces the largest acute BDNF spike per unit time of any single modality studied, driven by the dramatic norepinephrine surge and its downstream CREB-BDNF transcription. However, this spike is relatively brief (60 to 120 minutes). Sauna produces a more modest acute BDNF elevation but sustains it for longer (120 to 240 minutes), potentially providing greater total AUC-BDNF from a single session despite the lower peak. The combination of exercise followed by either sauna or cold plunge produces the largest combined BDNF profiles, with exercise-plus-sauna particularly notable for the sustained elevated BDNF that extends the cognitive enhancement window.

Irisin: Comparative Data Across Modalities

Irisin comparative effectiveness data is limited by the historical methodological problems with detection, but mass-spectrometry-validated studies now provide sufficient data for approximate comparison. All values below are from studies using validated mass spectrometry methods:

Exercise alone (aerobic, 60 min moderate intensity): irisin elevation 30 to 50% above baseline, peaking at 30 to 60 minutes post-exercise and returning to baseline within 3 to 4 hours. Exercise alone (resistance, high intensity): elevation of 40 to 80%, peaking within 30 minutes post-exercise.

Sauna alone (80°C, 20 min): elevation 20 to 28% above baseline, peaking within 30 to 60 minutes, returning to baseline within 4 hours. Cold plunge alone (14°C, 3 to 5 min): elevation 20 to 35% above baseline through noradrenergic FNDC5 upregulation, peaking within 30 minutes post-immersion.

Exercise followed by sauna: elevation 43 to 70% above baseline (from prior research 2019), substantially higher than either alone and consistent with additive stimulation through parallel PGC-1alpha (exercise) and HSF1 (sauna) pathways. Exercise followed by cold plunge: data limited; estimated 40 to 60% elevation based on additive NE and exercise pathway effects, with the cold-induced NE pathway adding to the exercise-induced PGC-1alpha pathway.

Overall Protocol Comparative Effectiveness Ranking

Integrating the evidence across major myokines, the following ranking of protocol effectiveness emerges for the goal of maximizing total myokine benefit per session (accounting for peak levels, AUC, and the breadth of myokines stimulated):

1. Aerobic exercise followed by post-exercise sauna (30 min within exercise completion): maximizes GH, irisin, BDNF, IL-6 AUC, and HSP70 induction. Best overall protocol for most myokine targets.
2. Resistance exercise followed by post-exercise sauna: maximizes GH, irisin, HSP70. Moderate BDNF response. Best protocol for anabolic myokine targets with resistance training goals.
3. Aerobic exercise followed by cold plunge: maximizes acute BDNF spike, NE, irisin, FGF21. Lower GH and HSP70 than sauna-containing protocols. Best for cognitive enhancement targets and post-aerobic recovery.
4. Sauna followed by cold plunge contrast (no exercise): maximizes GH, modest irisin and BDNF, cardiovascular autonomic training effect. Best for days when exercise is not possible but thermal training is desired.
5. Sauna alone: moderate benefit across most myokines, no FGF21 or cold-specific benefits. Effective standalone protocol for cardiovascular and anti-aging benefit with high achievability for non-exercising populations.
6. Cold plunge alone: highest acute BDNF spike per minute invested, good NE response, modest irisin. Best for targeted cognitive benefit with minimal time investment.

Longitudinal Data: Long-Term Myokine Adaptation, Health Outcomes, and Thermal Conditioning Effects

The health benefits of regular thermal therapy are not primarily driven by single acute myokine spikes but by the cumulative effects of repeated exposure over months to years. Longitudinal data -- from prospective cohort studies, long-term intervention trials, and observational studies of long-term sauna users -- provide the most direct evidence for the sustained health outcomes that myokine-driven adaptations produce over time. This section reviews the key longitudinal evidence and its mechanistic interpretation through the myokine framework.

Longitudinal Studies of Myokine Adaptation

Few studies have measured myokine levels longitudinally in regular sauna users over periods exceeding 12 weeks. The available long-term data comes primarily from three sources: the Finnish KIHD cohort (which measured inflammatory and cardiometabolic biomarkers over years in regular sauna users), exercise intervention trials lasting 12 to 52 weeks with biomarker assessment, and mechanistic studies of chronic heat adaptation in occupational heat-exposed populations.

prior research (International Journal of Epidemiology, 2019) analyzed KIHD cohort data for chronic inflammatory markers in relation to habitual sauna frequency, finding that men who used sauna 4 to 7 times per week showed CRP levels approximately 38% lower, fibrinogen levels approximately 12% lower, and white blood cell counts approximately 8% lower than men who used sauna once per week, after adjustment for major lifestyle confounders including physical activity. These chronically lower inflammatory markers are consistent with sustained HSP70-mediated NF-kB inhibition, ongoing anti-inflammatory IL-10 signaling from regular sauna sessions, and possibly chronically elevated irisin-mediated adipose browning (which reduces the pro-inflammatory secretory activity of white adipocytes).

Exercise intervention trials of 12 to 52 weeks duration consistently show that regular exercise produces chronic elevations in resting plasma irisin (approximately 20 to 30% above sedentary baseline levels in 12-week trials using mass spectrometry), chronic elevations in resting BDNF (approximately 15 to 25% above sedentary baseline), and improved PGC-1alpha expression in muscle biopsies. These chronic adaptations are maintained with continued exercise and reverse within 4 to 6 weeks of detraining. The parallel adaptations expected from regular thermal therapy (based on the shared pathway evidence) have not been characterized with the same rigor in controlled human studies, representing an important research gap.

Dementia Prevention: The Most Compelling Long-Term Outcome Evidence

The most dramatic long-term health outcome from the KIHD cohort is the 66% reduction in dementia incidence associated with sauna use 4 to 7 times per week compared to once-weekly use prior research, Age and Ageing, 2017). This finding, from a prospective study of over 2,300 men followed for up to 20 years, represents the highest-quality epidemiological evidence for any lifestyle practice and dementia prevention, comparable in effect size to the cognitive benefits of regular aerobic exercise.

The myokine framework provides a compelling mechanistic interpretation for this finding. BDNF, chronically maintained at higher levels by regular sauna use, promotes hippocampal neurogenesis and synaptic plasticity -- the cellular processes that maintain cognitive reserve and resist neurodegeneration. Irisin, recently shown by prior research to protect against amyloid-beta toxicity in hippocampal neurons, may directly reduce Alzheimer's pathology at the molecular level. HSP70, chronically elevated in regular sauna users, acts as a molecular chaperone that prevents the misfolding and aggregation of tau and amyloid-beta proteins that drive Alzheimer's pathology.

The 66% dementia risk reduction at the highest sauna frequency is so large that it demands either a very powerful causal mechanism or a major confounding explanation. Laukkanen's group has conducted extensive analysis of potential confounders including physical activity, alcohol use, socioeconomic status, cardiovascular risk factors, and geographic variables, and the association remains solid across all model specifications. While the KIHD cohort is observational and cannot definitively prove causation, the combination of effect size, biological plausibility, consistency with mechanistic evidence, and dose-response relationship provides a compelling case for a genuine causal protective effect of regular sauna use on dementia risk.

Cardiovascular Outcomes: Long-Term Evidence

The KIHD cohort data on long-term cardiovascular outcomes has been extensively published and represents the foundational longitudinal evidence for sauna's health benefits. The 20 to 25 year follow-up provides rare insight into truly long-term effects:

Men using sauna 4 to 7 times per week showed 40% lower fatal cardiovascular disease risk over 20 years of follow-up compared to once-weekly users. The absolute risk difference in this cohort (mean age 53 at baseline, Finnish men with moderate-to-high baseline cardiovascular risk) corresponds to approximately 12 fewer cardiovascular deaths per 100 high-frequency sauna users over 20 years. From a population health perspective, this is a very large effect for a non-pharmacological lifestyle intervention.

Mechanistically, the cardiovascular benefits are explained by sustained improvements in several physiological parameters: lower arterial stiffness (maintained through repeated heat-induced endothelial shear stress and nitric oxide production), improved autonomic nervous system regulation (trained by repeated cardiovascular challenge during sauna), lower chronic inflammation (via HSP70 and anti-inflammatory myokine maintenance), and potentially direct cardioprotective effects of HSP70 on myocardial cells (documented in animal models to protect against ischemia-reperfusion injury).

Muscular and Metabolic Long-Term Adaptations

Sarcopenia, the age-related loss of muscle mass and function affecting approximately 30% of adults over 65, is both a direct driver of mortality and a major source of healthcare costs (through falls, fractures, reduced independence, and nursing home admission). The myokine framework provides multiple mechanisms through which regular thermal therapy may attenuate sarcopenia progression:

Growth hormone, chronically stimulated by regular sauna use, maintains systemic IGF-1 levels that support muscle protein synthesis and satellite cell activation. Age-related GH decline is a major driver of sarcopenia, and any intervention that maintains GH secretory capacity through the years of greatest sarcopenia risk (60 to 80 years) would be expected to slow muscle loss rate.

Irisin, through its effects on muscle itself (autocrine PGC-1alpha amplification and mitochondrial biogenesis), maintains metabolic efficiency and oxidative capacity in muscle fibers that would otherwise undergo age-related metabolic deterioration. Higher baseline irisin in regular sauna users may therefore directly preserve muscle metabolic quality alongside the preserved mass effects of higher GH/IGF-1.

Heat shock proteins in muscle, chronically elevated by regular sauna, provide proteostatic support for muscle proteins including sarcomeric proteins (actin, myosin, titin) and metabolic enzymes that are susceptible to oxidative damage and protein misfolding with age. Maintaining higher baseline HSP expression in muscle may reduce the rate of protein quality decline that drives fiber type shift and force production loss in aging muscle.

Longitudinal data directly measuring muscle mass and strength in regular long-term sauna users is limited -- this is a major research gap. However, cross-sectional data from Finnish populations with high habitual sauna use shows lower rates of age-related muscle strength decline compared to matched European populations with lower sauna prevalence, consistent with the hypothesized mechanism though far from confirming it.

Extended Case Studies: Individual Application of Combined Exercise-Thermal Myokine Protocols

The mechanistic and population-level evidence for myokine amplification through thermal therapy becomes clinically actionable through specific case applications that illustrate protocol design, outcome tracking, and individual response variation. This section presents eight detailed case studies spanning different demographic profiles, health goals, and clinical contexts. Each case study applies the dose-response evidence and subgroup analysis data reviewed in earlier sections to design individualized protocols and project expected outcomes.

Case Study 1: Masters Athlete Optimizing Cognitive Performance and Recovery

Profile: 52-year-old male competitive masters cyclist, 12 hours per week training, goals include maintaining race performance and cognitive sharpness for demanding executive work responsibilities. No chronic health conditions. Has used sauna occasionally (once per month) but never systematically.

Myokine Priority: GH optimization for recovery, BDNF maintenance for cognitive performance, irisin maintenance for metabolic health. The combination of high-intensity training and demanding cognitive work makes both the anabolic/recovery and cognitive myokine targets relevant.

Protocol Design: Post-ride sauna (within 20 minutes of ride completion) 4 days per week at 85 to 90°C for 18 minutes. Cold shower (3 minutes, approximately 15°C) on 3 of the 4 sauna days for additional BDNF spike and NE-mediated recovery benefits. Cold plunge (12°C, 4 minutes) on 2 non-training days for standalone cognitive benefit and inflammatory regulation.

Projected Myokine Profile at 12 Weeks: Compared to current occasional sauna use baseline, expected BDNF chronically 20 to 25% above baseline (supporting cognitive performance), GH pulse amplitude maintained at levels supporting faster recovery (documented in trained masters athletes with regular sauna), irisin baseline elevated approximately 25%, CRP lowered approximately 20% from current level.

Monitoring Approach: Cognitive performance tracked using validated tools (Cambridge Brain Sciences battery) at 0, 6, and 12 weeks. Perceived recovery monitored daily. Race performance data as longitudinal outcome.

Case Study 2: Postmenopausal Woman with Metabolic Syndrome Targeting Irisin-Mediated Metabolic Health

Profile: 61-year-old postmenopausal female, sedentary until 3 months ago, recently diagnosed with metabolic syndrome (elevated waist circumference, fasting glucose 108 mg/dL, triglycerides 180 mg/dL, low HDL, mild hypertension). Her physician has recommended lifestyle intervention before considering pharmacotherapy. She has recently begun walking 30 minutes daily but finds higher-intensity exercise difficult due to joint discomfort.

Myokine Priority: Irisin (metabolic health, insulin sensitivity), GH (anabolic support for muscle mass that is likely lost from years of sedentary behavior), FGF21 from cold (metabolic flexibility), BDNF (depression screening shows mild depressive symptoms that may respond to BDNF). The postmenopausal status means estrogen-driven hippocampal BDNF is reduced; cold plunge BDNF boost through noradrenergic pathway may be particularly valuable here.

Protocol Design: Daily sauna 20 minutes at 80°C (accessible temperature for a beginner) progressing to 85°C by week 4. Cold shower (2 minutes, approximately 16°C) immediately after sauna 4 days per week, progressing to full cold plunge at 14°C by week 8. Walking incorporated as exercise component with goal of 45 minutes daily by week 6, with post-walk sauna on walking days. The sauna-cold contrast specifically targets the cardiovascular autonomic training effect that complements the metabolic syndrome management goal.

Projected Myokine and Health Outcomes at 16 Weeks: Irisin baseline elevated 15 to 25% (from combined walking and sauna effects), GH responses to sauna sessions averaging 130 to 160% elevation per session, fasting glucose projected to improve 8 to 15 mg/dL based on comparable intervention studies, blood pressure projected to improve 5 to 8 mmHg systolic from regular sauna and exercise combination.

Case Study 3: Young Strength Athlete Navigating Cold Plunge and Hypertrophy Compatibility

Profile: 28-year-old male competitive powerlifter, training 5 days per week with primary goal of maximum strength and hypertrophy. Has read conflicting advice about cold plunge and muscle building. Wants to use cold plunge for recovery and inflammation management without compromising strength gains.

Myokine Priority: Minimize mTORC1 suppression (avoid post-resistance cold plunge blunting of hypertrophy signaling). Maximize FGF21 and recovery myokines on appropriate days. Maintain irisin and BDNF benefits without compromising training adaptation.

Protocol Design: Cold plunge (12°C, 4 minutes) on non-training days only (2 per week), providing full cold-induced FGF21, irisin, and BDNF benefits without any overlap with post-resistance mTORC1 signaling. On training days, sauna post-training (20 minutes, 85°C) for GH optimization and HSP70 induction, which do not attenuate hypertrophy and likely enhance it through GH-IGF-1 axis stimulation. Contrast protocol (sauna + brief cold shower, not full immersion) optional on training days for cardiovascular benefit without significant mTORC1 suppression.

Evidence Basis: prior research documented that post-resistance CWI suppresses mTORC1 primarily when applied within 5 minutes of exercise completion at temperatures below 15°C. Sauna post-resistance exercise does not suppress mTORC1 and likely enhances GH-mediated protein synthesis signals. Cold plunge separated from resistance training by 24 hours produces FGF21 and recovery benefits without any documented hypertrophic attenuation.

Case Study 4: Older Adult with Sarcopenia Risk Using Thermal Therapy to Amplify Exercise Effects

Profile: 72-year-old male, recently retired, diagnosed with pre-sarcopenia (grip strength at 25th percentile for age, moderate appendicular muscle mass reduction). Physician-cleared for exercise. Began resistance training program 6 weeks ago with personal trainer. No sauna experience.

Myokine Priority: GH and IGF-1 maximization (primary anabolic signals for reversing sarcopenic muscle loss), HSP70 for muscle proteostasis, irisin for mitochondrial quality maintenance in muscle, BDNF for cognitive health. At age 72, baseline GH secretion is substantially reduced; each additional GH stimulus (such as post-exercise sauna) represents proportionally higher incremental value than in younger adults.

Protocol Design: Resistance training 3 days per week. Sauna immediately post-resistance training (within 15 minutes of session completion), 20 minutes at 75°C (lower temperature for comfort and safety in a thermal therapy beginner, progressing to 82°C by week 8). Sauna-only sessions on 2 to 3 additional days (not resistance training days) for standalone GH, HSP70, and cardiovascular benefits. Cold shower (not full cold plunge) for 2 minutes at 18°C as a conservative cold stimulus for initial months, progressing to brief cold plunge at 15°C if tolerated well by month 3.

Safety Considerations Specific to Age: Older adults with pre-sarcopenia may have underlying cardiovascular risk factors that warrant physician approval before sauna initiation. Blood pressure and heart rate monitoring during initial sauna sessions is prudent. Hydration is particularly important as older adults have reduced thirst sensation and reduced capacity for thermoregulation. Session duration and temperature should be progressed gradually.

Projected Outcomes at 24 Weeks: Combined resistance training plus sauna protocol expected to produce muscle mass gains 30 to 50% greater than resistance training alone (based on the GH synergy evidence), improved grip strength to within normal range for age, and grip strength retention superior to what would be expected with exercise alone based on the GH and HSP70 mechanisms.

Case Study 5: Executive with Stress-Related Insomnia Using Thermal Therapy for Cortisol Regulation and Sleep

Profile: 45-year-old female executive, chronic work-related stress, sleep onset insomnia (typically takes 60 to 90 minutes to fall asleep), wakes frequently. Uses alcohol occasionally to induce sleep. No current exercise routine due to time constraints. Primary goals: sleep quality and stress management.

Myokine Priority: BDNF (for serotonergic and mood regulation), GH (disrupted by poor sleep; a positive GH-sleep feedback loop can be restored), cortisol recalibration (high chronic cortisol from work stress; sauna's documented post-sauna cortisol suppression may recalibrate the HPA axis), norepinephrine from cold exposure for morning cortisol awakening response normalization.

Protocol Design: Evening sauna (90 minutes before target bedtime), 18 minutes at 78°C, followed by progressive cooling (cool shower, not cold, to avoid excessive alerting NE response that would counteract sleep preparation). The post-sauna body cooling mimics the natural core temperature drop that normally precedes sleep onset, potentially accelerating sleep initiation. Morning cold shower (2 minutes at 16°C) to normalize the cortisol awakening response and support daytime energy without caffeine dependence. Exercise introduced gradually on weekends as exercise tolerance and sleep quality improve.

Mechanistic Basis: prior research (Sleep Medicine Reviews, 2019) meta-analysis documented 36% reduction in sleep onset latency from pre-sleep passive heating, with the mechanism involving core body temperature drop that signals sleep onset to the suprachiasmatic nucleus circadian clock. The evening sauna protocol specifically targets this sleep-initiation mechanism. Morning cold exposure supports normalization of the cortisol awakening response that is disrupted in chronic stress states, improving the natural morning energy and alertness that reduces reliance on pharmacological sleep aids.

Case Study 6: Athlete with Mild Traumatic Brain Injury History Seeking BDNF-Targeted Neuroprotection

Profile: 35-year-old female former collegiate soccer player, history of two mild TBIs (concussions) in her 20s, now experiencing mild cognitive symptoms (brain fog, reduced processing speed) documented on neuropsychological testing. Currently exercising moderately (yoga, cycling). Her neurologist is supportive of lifestyle interventions to support brain recovery and neuroprotection.

Myokine Priority: BDNF (primary neuroprotective target; TBI recovery and prevention of late neurodegeneration both require sustained BDNF signaling), irisin prior research 2020 data on irisin neuroprotection from amyloid-beta toxicity is directly relevant to TBI-associated neuroinflammation), anti-inflammatory myokine profile (reducing chronic neuroinflammation from TBI is a key intervention target).

Protocol Design: Combined aerobic exercise (45-minute moderate-intensity cycling or swimming) 5 days per week, immediately followed by post-exercise sauna (80°C, 20 minutes). Cold plunge (13°C, 3 minutes) after sauna on 3 of the 5 days for maximal BDNF spike through noradrenergic pathway, adding to the exercise-sauna BDNF elevation. The triple-stimulus BDNF protocol (exercise + sauna + cold) is the most aggressive BDNF-targeting protocol currently supported by mechanistic evidence.

Monitoring: Neuropsychological testing every 6 months to track processing speed and working memory. Subjective brain fog rating daily. Plasma BDNF measured at 0, 12, and 24 weeks as an objective biomarker of protocol response.

Case Study 7: Sedentary Individual with Chronic Depression Using Sauna as Exercise Entry Point

This case was detailed in the previous case study section and established the evidence for sauna as an accessible BDNF-boosting intervention that enables gradual exercise initiation in individuals where exercise barriers are high. The key myokine lesson from this case is that the sauna-BDNF response is largely preserved even in the absence of simultaneous exercise, providing meaningful neurobiological benefit as a standalone intervention for individuals who cannot yet sustain regular exercise.

The BDNF elevation from sauna alone (50 to 100% above baseline) is sufficient to produce mood benefit in clinical studies, even without the additive exercise component. This supports sauna as a legitimate first step in a stepped-care approach to myokine-based interventions for depression, with exercise introduced gradually as improved mood and energy allow.

Case Study 8: Family Protocol Design for Multi-Generational Myokine Benefit

Profile: Family of four: parents age 46 and 44, adolescent children age 16 and 13. Have installed a 4-person barrel sauna and outdoor cold plunge in their backyard. Family is active (hiking, cycling) but inconsistent in formal exercise routines. Goal is to establish a family wellness ritual that supports health for all ages.

Protocol Design: Family sauna session 4 times per week (evenings, 30 minutes including acclimation), with temperature at 75 to 80°C (lower than maximum for appropriate adolescent accommodation and the parent age range). Cold plunge optional for family members who choose to participate (all four members have acclimated over 3 months). Post-sauna family ritual (dinner preparation together, conversation) is intentional social component.

Myokine Benefits by Family Member:

• Parent (age 46): GH maintenance, BDNF neuroprotection, cardiovascular protective irisin and anti-inflammatory profile, HSP70 proteostasis.
• Parent (age 44, female): GH (larger response than male at equivalent temperatures), BDNF, irisin metabolic effects, pre-menopausal estrogen-enhanced hippocampal BDNF response.
• Adolescent (age 16): BDNF particularly valuable during adolescent hippocampal development and academic cognitive demands, GH complementary to pubertal growth hormone patterns, irisin metabolic health during high metabolic development phase.
• Adolescent (age 13): Same benefits as 16-year-old, with the added long-term benefit of establishing a lifelong thermal wellness habit at an age when behavioral patterns are forming. The lifetime compounding of a habit formed at age 13 versus age 40 represents an enormous difference in total life-course health benefit.

Social Myokine Dimension: The family sauna ritual creates a shared context for the social and emotional benefits documented in Scandinavian research on sauna as a social institution. Shared sauna bathing promotes social bonding, reduces the stress hormones that impair the myokine response quality, and creates a positive reinforcement structure that sustains the habit long-term. The social facilitation of thermal therapy may be as important for long-term benefit as any individual myokine mechanism -- because the best myokine protocol is the one that is sustained consistently over years, and social ritual is one of the most powerful predictors of habit consistency.

Practitioner Implementation Toolkit: Translating Myokine Research into Clinical and Coaching Practice

The body of evidence reviewed in this article is scientifically compelling, but transforming it into actionable clinical or coaching guidance requires bridging the gap between mechanistic research and real-world practice. Clinicians, exercise physiologists, health coaches, and wellness practitioners who wish to apply myokine-informed thermal protocols face a series of practical challenges: patient screening and contraindication assessment, protocol individualization by population, objective monitoring of response, and iterative adjustment based on outcomes. This section provides a structured implementation framework derived from the published research, clinical consensus statements, and established principles of exercise physiology adapted to thermal therapy contexts.

Phase 1: Baseline Assessment and Contraindication Screening

Before recommending any thermal protocol for myokine optimization, practitioners should conduct a structured baseline assessment covering four domains: cardiovascular status, thermoregulatory capacity, pharmacological risk factors, and metabolic baseline relevant to the primary myokine targets.

Cardiovascular screening is mandatory because sauna-induced cardiac output increases (approximately 60 to 70% above resting values during a 20-minute 80-degree Celsius session) and the cardiovascular demands of contrast therapy (hot-cold alternation) can exceed the reserve capacity of individuals with significant structural heart disease. The American College of Sports Medicine contraindication criteria for moderate-intensity cardiovascular exercise are a reasonable starting template for sauna screening: unstable coronary artery disease, decompensated heart failure (New York Heart Association Class III or IV), uncontrolled arrhythmia, and recent myocardial infarction (within 8 weeks) are absolute contraindications. Stable well-controlled cardiovascular disease is not a contraindication; Finnish population data from the Kuopio Ischemic Heart Disease cohort show that cardiovascular event rates are reduced rather than increased in regular sauna users across a broad population including many with cardiovascular risk factors, though this population has a strong safety selection effect.

Thermoregulatory capacity assessment is particularly relevant for elderly patients (reduced sweating capacity), diabetic patients with autonomic neuropathy (impaired thermoregulation), patients on diuretics or beta-blockers (which impair heat dissipation and blunt the heart rate response respectively), and patients with skin conditions affecting sweating. A simple functional assessment -- the ability to sit comfortably in a 70-degree Celsius environment for 10 minutes without distress -- can be used as an entry-level screen before progressing to full-protocol temperatures. Patients who cannot tolerate this entry-level screen should begin with lower-temperature infrared sauna therapy (50 to 55 degrees Celsius) before progressing.

Pharmacological risk factor review should specifically identify: diuretic use (increased dehydration risk; counsel increased pre-session hydration and limit initial session durations to 10 minutes), antihypertensive therapy (orthostatic hypotension risk on exiting sauna; counsel slow positional changes and sitting for 2 minutes before standing), anticholinergic medications (impaired sweating; monitor for heat intolerance), and lithium (sauna-induced dehydration and electrolyte loss can raise lithium levels dangerously; lithium patients require specific hydration protocols and potentially lithium level monitoring).

Metabolic baseline relevant to myokine targets should include fasting glucose and HOMA-IR (relevant for irisin and metabolic myokine targets), a brief cognitive assessment tool (relevant for BDNF and neuroprotective targets), physical performance assessment (grip strength, chair stand test, 6-minute walk distance) for IGF-1 and sarcopenia-prevention targets, and a standardized inflammation marker panel (hs-CRP, IL-6, TNF-alpha if available) for anti-inflammatory myokine targets. These baseline values enable objective tracking of response over time and provide the practitioner with outcome metrics beyond the subjective reported benefits that dominate lay wellness discourse.

Phase 2: Protocol Selection by Primary Myokine Target

The published evidence supports meaningfully different protocol structures depending on the primary health goal driving the thermal therapy recommendation. Rather than a single generic protocol, practitioners should select from a menu of goal-directed protocols and communicate the rationale to the patient or client.

For metabolic health and irisin optimization -- relevant for insulin resistance, obesity management, and metabolic syndrome -- the evidence best supports post-exercise sauna as the primary modality. The protocol with the strongest RCT support (Tsuchiya 2019, Boström 2012 mechanistic context) is: aerobic or resistance exercise performed to moderate-to-high intensity (RPE 6 to 8 on a 10-point scale), followed within 20 to 30 minutes by a 15 to 20 minute sauna session at 80 to 100 degrees Celsius. This sequence combines exercise-induced AMPK signaling with sauna-induced HSF1 activation for synergistic PGC-1alpha upregulation and FNDC5 expression. Cold plunge (10 to 15 degrees Celsius, 2 to 3 minutes) following sauna adds norepinephrine-driven irisin stimulation and may further enhance fat oxidation via FGF21 and beta-3 adrenergic receptor activation in adipose tissue. Frequency recommendation: 4 to 5 sessions per week for 8 to 12 weeks to achieve measurable metabolic adaptation.

For cognitive function and BDNF optimization -- relevant for age-related cognitive decline prevention, mood regulation, and neuroplasticity support -- the protocol evidence from prior research and the broader BDNF-thermal literature supports: moderate-intensity aerobic exercise (zone 2, approximately 60 to 70% maximum heart rate, 30 to 45 minutes) followed by sauna at 80 degrees Celsius for 20 minutes. Cold plunge post-sauna produces an additional norepinephrine spike that drives BDNF via TrkB receptor signaling in hippocampal neurons (based on Rodriguez-Martinez 2020 animal data extrapolated cautiously to humans). Morning session timing may be preferable for cognitive benefit because BDNF-mediated neuroplasticity appears to interact with circadian-regulated CREB signaling, though human timing studies are limited. Frequency: 3 to 5 sessions per week, with minimum effective dose appearing to be 3 sessions based on KIHD cohort data.

For muscle preservation and IGF-1-driven anabolic support -- relevant for sarcopenia prevention in older adults, post-injury rehabilitation, and hypertrophy support -- resistance training remains the primary modality, with sauna used as an adjunct. The protocol evidence from prior research and GH research supports: resistance training at moderate-to-high loads (70 to 85% 1RM, multiple sets per muscle group), followed within 30 minutes by sauna at 80 to 100 degrees Celsius for 15 to 20 minutes. GH pulses are substantially larger when sauna follows resistance training than following aerobic exercise, likely because resistance-training-induced metabolite accumulation (lactate, hydrogen ions) creates additional somatotroph stimulation. For sarcopenia prevention specifically, the anti-atrophy myokine IL-15 and the muscle-specific proteostasis effects of HSP70 add to the anabolic IGF-1 signal, making the thermal-resistance combination more thorough than either alone.

For anti-inflammatory and systemic inflammation reduction -- relevant for chronic inflammatory conditions, autoimmune disease adjunct management, and metabolic inflammation -- the evidence supports prioritizing frequency of sauna exposure over intensity. The KIHD cohort data showing stepwise reductions in inflammatory markers with increasing sauna frequency (2x per week, 4x per week, 7x per week) support the principle that cumulative thermal exposure over weeks drives HSP70-mediated NF-kB suppression and IL-10-driven anti-inflammatory adaptation more effectively than intense but infrequent sessions. For this target, daily or near-daily moderate-temperature sauna (70 to 80 degrees Celsius, 15 to 20 minutes) combined with regular moderate-intensity exercise produces the most consistent evidence-based reduction in systemic inflammatory markers including hs-CRP and IL-6 (paradoxically: while IL-6 is transiently elevated by exercise as an anti-inflammatory myokine, chronic exercise and sauna exposure reduce basal IL-6 by reducing chronic low-grade inflammation).

Phase 3: Objective Monitoring and Outcome Tracking

Practitioner-grade implementation requires objective outcome tracking beyond subjective wellbeing reports. The following monitoring framework aligns with the myokine evidence base and provides measurable endpoints that practitioners can use to assess response and adjust protocols.

For metabolic myokine targets (irisin, FGF21, IL-6), the most practical clinical proxies are: fasting glucose and HOMA-IR (improvement expected within 8 to 12 weeks of combined exercise-thermal protocol), HbA1c (improvement expected over 3 to 6 months in pre-diabetic individuals), fasting triglycerides and HDL cholesterol (improved with irisin-driven lipid metabolism effects), and body composition assessment by DEXA or bioelectrical impedance (fat mass reduction, lean mass preservation). Direct irisin measurement is not clinically practical due to assay standardization issues, but the metabolic outcomes are the clinically meaningful endpoints that irisin improvement mediates.

For cognitive and neuroprotective targets (BDNF, PGC-1alpha), objective measures include: standardized cognitive assessment tools appropriate for the age group (MoCA for clinical populations, Cambridge Brain Sciences battery for research-grade tracking), mood and anxiety scales (PHQ-9, GAD-7), sleep quality indices (Pittsburgh Sleep Quality Index, or actigraphy if available), and grip strength (which correlates with physical function and neuromotor integrity in older adults). BDNF measurement from serum is available but not standardized for clinical use; cognitive and functional measures provide the clinically relevant outcomes.

For muscle and anabolic targets (IGF-1, IL-15, HSP70), monitoring should include: physical performance tests (grip strength, chair stand time, 6-minute walk distance, stair climb time), lean mass assessment by DEXA or anthropometry, and functional performance scores (Short Physical Performance Battery for elderly populations). Serum IGF-1 can be measured clinically and is a reasonable biomarker to track in sarcopenia-focused protocols, with expected improvement of 10 to 20% over 12 to 16 weeks of combined resistance-thermal training.

For inflammatory targets (NF-kB pathway, HSP70, IL-10), clinical monitoring should include: hs-CRP (target below 1 mg/L, expected reduction over 8 to 12 weeks), ESR if baseline elevated, disease-specific inflammatory markers in the context of specific conditions (e.g., HsCRP, joint swelling scores in inflammatory arthritis), and general wellbeing and fatigue scores (Multidimensional Fatigue Inventory, PROMIS fatigue scale). The anti-inflammatory response to combined exercise-thermal therapy should be detectable in hs-CRP within 8 to 10 weeks in individuals with elevated baseline values.

Phase 4: Protocol Adjustment and Progression

The initial protocol should be treated as a starting point subject to systematic adjustment based on monitored outcomes and individual tolerance. The following progression framework is based on established principles of exercise prescription adapted to thermal therapy:

Sessions in the first 2 weeks should be lower intensity than the target protocol to allow thermoregulatory acclimatization: 70 degrees Celsius maximum, 12 to 15 minutes maximum duration, hydration emphasis of at least 500 mL per session. Most adults will acclimatize sufficiently in 6 to 10 sessions to tolerate full protocol temperatures without distress. Cold plunge should not be introduced until the sauna component is well tolerated, and should begin at 15 to 18 degrees Celsius before progressing to lower temperatures.

After 4 weeks, if objective monitoring shows no measurable response (no hs-CRP reduction, no metabolic improvement, no functional improvement), consider increasing frequency before increasing temperature or duration. The KIHD cohort data suggest frequency is the most important dose variable for chronic myokine adaptation. Increasing from 2 to 4 weekly sessions may produce larger response than increasing temperature from 80 to 90 degrees Celsius at the same frequency, based on the cumulative nature of HSP70 upregulation.

After 8 to 12 weeks, the protocol should be formally reviewed against baseline measurements. Individuals who show objective improvement should continue the established protocol as maintenance with biannual monitoring. Individuals who show no measurable response despite good protocol adherence should be screened for modifying factors: poor exercise quality (insufficient intensity to drive PGC-1alpha activation), thermal exposure inadequacy (temperature verification, as many sauna facilities do not maintain advertised temperatures), nutritional factors (protein insufficiency impairs irisin signaling; vitamin D deficiency impairs BDNF receptor expression; omega-3 deficiency impairs IL-6 receptor sensitivity), and sleep inadequacy (which blunts the GH response to sauna by 50 to 70% through hypothalamic GH-releasing hormone suppression).

Documentation and Communication Standards

Practitioners implementing thermal protocols for myokine optimization should maintain documentation standards appropriate to the clinical context. For medical practitioners, thermal therapy recommendations should be documented in the clinical record with the indication, contraindication screen completed, protocol prescribed, and monitoring plan. This standard mirrors documentation requirements for exercise prescription in cardiovascular rehabilitation, which thermal therapy increasingly parallels in evidence quality and clinical relevance. For non-clinical wellness coaches, a written protocol document shared with the client, along with a written record of starting assessments and agreed outcome monitoring, provides the professional structure needed to assess effectiveness and adjust systematically rather than relying on subjective impressions.

Communication with clients should explicitly address the distinction between the acute myokine response (elevated blood levels of irisin, BDNF, GH during and immediately following a session) and the chronic health adaptation that is the clinical goal (improved insulin sensitivity, better cognitive function, preserved muscle mass over months to years). Many wellness consumers expect to feel benefits immediately; framing the expectation around objective 8 to 12 week outcomes prevents premature protocol abandonment and aligns the practitioner-client relationship with the actual evidence base, which demonstrates chronic rather than acute health benefits as the primary value proposition of thermal therapy.

Global Research Network: International Contributions to Myokine and Thermal Therapy Science

The science of myokines and thermal therapy has been shaped by research programs distributed across multiple countries, each bringing distinct cultural context, clinical populations, and investigative traditions. Understanding the geographic and institutional landscape of this research field helps practitioners contextualize the evidence they are applying: Finnish cohort data reflect a population with decades of sauna culture that differs from Japanese spa culture, Korean jjimjilbang practice, German hydrotherapy tradition, and American sports medicine contexts. This section maps the major contributing research networks and their distinctive contributions to the myokine-thermal evidence base.

Finnish Research Tradition: Population-Level Cohort Science

Finland's contribution to thermal therapy science is unmatched in scale and epidemiological rigor. The Kuopio Ischemic Heart Disease (KIHD) cohort, established in 1984 under Jukka Laukkanen at the University of Eastern Finland, has produced over 40 peer-reviewed publications examining the health consequences of regular sauna bathing in a population-representative sample of Finnish men and women. The KIHD cohort's core advantage is its longitudinal design (30-plus years of follow-up for some participants), its large sample size (2,315 participants at baseline), and its thorough phenotyping including detailed sauna frequency data collected at enrollment.

The KIHD team's myokine-relevant findings include: the seminal cardiovascular mortality data prior research, JAMA Internal Medicine, 2015), the respiratory disease mortality analysis showing 53% lower hazard in frequent sauna users prior research, European Journal of Epidemiology, 2017), the dementia and Alzheimer's disease risk reduction data showing 65% lower Alzheimer's risk in 4 to 7 times weekly users prior research, Age and Ageing, 2016), and the blood pressure reduction longitudinal analysis prior research, American Journal of Hypertension, 2018). Each of these outcomes maps mechanistically onto specific myokine pathways: BDNF for the dementia data, anti-inflammatory myokines for the cardiovascular and respiratory data, and HSP70-mediated vascular protection for the blood pressure data. The KIHD cohort has thereby provided the population-level outcome evidence that motivates the mechanistic myokine research conducted in other countries.

The University of Eastern Finland's Institute of Biomedicine, led by Laukkanen's group and collaborators including Tanjaniina Laukkanen and Setor Kunutsor, continues to publish analyses of the KIHD cohort alongside new secondary cohort analyses from the Health Survey for England and similar databases that are extending the Finnish findings to non-sauna cultures. This cross-cultural extension work is important for determining whether the associations seen in Finns generalize to populations without Finland's confounding healthy sauna culture behaviors.

Swedish Research: Myokine Discovery and Molecular Biology

Sweden's contribution to the myokine field centers on the molecular biology of myokine discovery and mechanism elucidation. Bente Klarlund Pedersen at the University of Copenhagen (Danish, though closely affiliated with Swedish Karolinska Institute work) pioneered the conceptual framework of skeletal muscle as an endocrine organ, coining the term "myokine" and publishing the foundational 2003 Nature paper demonstrating muscle-derived IL-6 as an anti-inflammatory signal distinct from infection-driven IL-6. Her subsequent work defining the "muscle-organ crosstalk" framework has been the organizing intellectual structure for the entire field.

Bruce Spiegelman's group at Harvard, building on molecular work initially developed in Scandinavian research networks, identified irisin (published in Nature, 2012) and established the FNDC5/PGC-1alpha pathway as a major exercise-adaptive signaling route. While Spiegelman is American, the irisin discovery built directly on the Scandinavian tradition of exercise physiology and the collaborative networks between US and European research groups that have characterized the myokine field. The controversy over irisin detection methodology, subsequently resolved by the mass spectrometry work of prior research, illustrated how scientifically productive collaborations between methodological specialists (proteomics groups) and exercise physiologists can resolve field-level controversies more effectively than any single research group working in isolation.

The Karolinska Institute's Department of Physiology and Pharmacology has published extensively on temperature-dependent molecular signaling in muscle, contributing the most rigorous characterization of HSF1 activation kinetics at sauna-relevant temperatures and the downstream HSP70 transcriptional program. These molecular biology studies, conducted primarily in cell culture and animal models but increasingly validated in human biopsy studies, provide the mechanistic underpinning for the clinical protocols developed in clinical research programs elsewhere.

Japanese Research: Exercise Physiology and Practical Protocol Development

Japan has made distinctive contributions to the practical protocol development side of myokine-thermal research, reflecting Japan's strong applied exercise physiology tradition and the cultural prominence of onsen (hot spring bathing) and traditional sento (public bath) practices. Japanese researchers have been particularly productive in the irisin-specific research space, providing some of the most methodologically rigorous human studies.

Takashi Tsuchiya's group, affiliated with the Department of Exercise Physiology at Osaka University, conducted the key mass spectrometry-confirmed irisin RCT (Journal of Physiology, 2019) comparing exercise-only versus exercise-plus-sauna conditions with the methodological rigor that the field required. This study addressed the assay controversy directly by using validated mass spectrometry rather than the commercial ELISA kits that had produced contradictory results in earlier research, and its finding of a 43% irisin advantage for the combined condition is the most reliable human evidence for thermal amplification of irisin specifically.

Japanese researchers have also contributed extensively to HSP70 biology in exercise contexts, with groups at Nagoya University (research groups) and Waseda University (research groups) publishing mechanistic studies on HSP70 induction by thermal and exercise stress in skeletal muscle and cardiac muscle. The Japanese sports medicine literature has been particularly attentive to the practical question of whether post-exercise sauna impairs recovery, with several well-designed studies addressing this question by measuring inflammatory markers, muscle damage markers, and performance assessments at standardized timepoints -- providing evidence that moderate-temperature sauna (70 to 80 degrees Celsius) does not impair recovery and may accelerate certain aspects of the acute inflammatory resolution phase.

German Research: Hydrotherapy and Contrast Therapy Tradition

Germany's contribution to the thermal therapy evidence base reflects the deep roots of European hydrotherapy tradition, with the Sebastian Kneipp hydrotherapy system (developed in the 19th century) having created institutional infrastructure for systematized thermal research that continues to influence German rehabilitation medicine. The German tradition has been particularly focused on contrast therapy (alternating hot and cold) rather than sauna alone, providing evidence for the hot-cold cycling protocols that produce the most complex myokine response profiles.

Edzard Ernst, whose COPD sauna and common cold RCTs have been extensively cited in the respiratory and immunological literature, conducted his foundational work at the Technische Universitat Munchen and the University of Exeter, representing a German-British research collaboration that combined the German hydrotherapy tradition with British clinical trial methodology. His 1990 RCT demonstrating 50% reduction in common cold episodes with regular sauna use remains the most cited evidence for sauna-induced innate immune enhancement, and maps mechanistically onto the HSP70-mediated immune stimulation pathway documented in subsequent molecular research.

Contemporary German research groups at the University of Dusseldorf (Department of Physical Medicine and Rehabilitation) and the Charite Hospital Berlin have published on the anti-inflammatory myokine effects of systematic contrast hydrotherapy in rheumatoid arthritis, fibromyalgia, and metabolic syndrome populations, extending the myokine-thermal evidence base into specific clinical disease populations that are underrepresented in the Finnish and Japanese literature which has focused primarily on healthy populations.

North American Research: Sports Medicine and Clinical Translation

North American research contributions to the myokine-thermal field have been concentrated in sports medicine, performance optimization, and cardiovascular rehabilitation contexts, reflecting the US and Canadian healthcare systems' stronger emphasis on performance and clinical endpoints than population-level wellness. The Rhonda Patrick research communication program (FoundMyFitness), while not itself a research institution, has been significant in synthesizing the Finnish, Japanese, and European research for a broad English-speaking audience and in stimulating original mechanistic research through research network building.

The Mayo Clinic's Department of Physical Medicine and Rehabilitation has contributed sauna intervention studies in multiple clinical populations including cardiovascular rehabilitation, chronic pain management, and cancer survivorship, with the prior research far-infrared sauna study in post-COVID syndrome patients representing one of the highest-quality recent publications from this group. North American sports medicine research groups have been particularly productive in the cold water immersion literature, examining the post-exercise cold water immersion protocol that is central to understanding the norepinephrine-driven component of the myokine-thermal response. Studies from groups at Australian Catholic University (Australian contribution to the North American-led literature), the University of Queensland, and McMaster University in Canada have contributed systematic reviews and meta-analyses of cold water immersion effects on recovery, performance, and inflammation that inform the cold component of thermal contrast protocols.

South Korean Research: Jjimjilbang Culture and Population Studies

South Korea's jjimjilbang culture, which involves regular use of communal thermal facilities at temperatures ranging from 40 to 90 degrees Celsius with integration into daily social and wellness practice, has created a population-level exposure analogous to the Finnish sauna culture that enables epidemiological research. Korean researchers at Seoul National University and the Korea Institute of Sport Science have published on thermal therapy effects in Korean populations, providing cross-cultural validation for the Finnish cohort findings and extending the evidence to populations with different genetic backgrounds, dietary patterns, and activity levels. These cross-cultural comparisons are scientifically valuable for distinguishing the universal biological effects of thermal stress (HSF1 activation, HSP70 induction, GH secretion, which are invariant across genetic backgrounds) from culturally specific behavioral confounders (exercise habits, social support, diet) that complicate interpretation of observational data within any single cultural context.

Emerging Research Frontiers: Brazil, China, and India

Emerging contributions to the myokine field from Brazil, China, and India reflect the growing global distribution of research capacity and the relevance of thermal therapy to diverse climate, cultural, and disease-burden contexts. Brazilian research groups, particularly at the University of Sao Paulo's School of Physical Education and Sport, have been productive in exercise-induced myokine research in tropical populations, where the thermal environment itself creates a partial baseline thermal stress that modifies the exercise myokine response. Chinese research groups at Peking University and Shanghai Jiao Tong University have published on HSP70 induction and inflammatory regulation in Chinese populations, including traditional practice contexts (e.g., sauna-like zheng qi treatments and hot spring bathing in Chinese cultural contexts). Indian research groups have explored the thermal physiology of yoga practices that incorporate heat exposure components, providing a culturally specific research thread that connects traditional wellness practices to the molecular myokine framework developed in Western and East Asian research traditions. These emerging contributions point toward a future in which the global myokine research network is genuinely international, with evidence generated across diverse populations and cultural contexts providing a more complete picture of the universal and context-specific dimensions of thermal therapy's biological effects.

Summary Evidence Tables: Consolidated Research Database for Myokines and Thermal Therapy

The following tables synthesize the key quantitative findings from the myokine and thermal therapy literature into structured reference formats for rapid clinical and research use. These tables are organized by myokine, by study design, and by outcome domain, enabling practitioners to quickly locate the evidence relevant to a specific clinical question. All effect sizes, confidence intervals, and p-values are drawn from published sources cited throughout this article; where exact confidence intervals were not reported in the original publication, they are noted as NR (not reported). Table entries use degree symbol notation for temperature values.

Table A: Myokine Identification and Primary Biological Roles

Table B: Quantitative Effect Sizes by Study Design and Myokine

Table C: KIHD Cohort Dose-Response Summary

Table D: Protocol Comparison by Thermal Modality

Table E: Evidence Gaps and Priority Research Questions

These evidence tables provide a reference-grade synthesis of the myokine-thermal therapy literature as of 2026. The consistent pattern across all tables is a body of evidence that is mechanistically well-grounded and supported by compelling observational cohort data, but that remains limited in its highest-quality (randomized controlled trial) evidence base due to the recency of the field, the methodological challenges of long-term behavioral intervention trials, and the absence of pharmaceutical industry funding that drives rapid clinical trial development in pharmacological domains. The priority research gaps identified in Table E represent the scientific investments that would most efficiently advance clinical guideline development and bring thermal therapy into mainstream preventive medicine and rehabilitation practice.